The 20 Best Diffuse Midline Glioma H3 K27M-Mutant Doctors Near Me in Bronx, NY

Oren Becher is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Becher is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Brain Stem Cancer, and Medulloblastoma.

Ira Dunkel is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Dunkel is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, and Glioma. Dr. Dunkel is currently accepting new patients.

Keyur Mehta is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Throat Cancer, Cervical Cancer, and Colonoscopy.

Jana Fox is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Fox is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Throat Cancer, and Laryngeal Cancer.

Justin Tang is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Tang is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Benjamin Himes, MD, PhD, MHS, is an attending physician and Assistant Professor of Neurological Surgery at Montefiore Einstein. He specializes in cranial neurosurgical oncology, particularly in the treatment of intrinsic brain tumors in eloquent regions, including awake surgery with motor and speech mapping. Dr. Himes is particularly interested in the treatment of low-grade gliomas and glioblastoma. He also specializes in the treatment of metastatic disease to the brain, intraventricular tumors and extra-axial lesions including meningiomas. Dr. Himes has extensive experience with state-of-the-art surgical approaches, including the use of intraoperative ultrasound, 5-ALA, laser interstitial therapy (LITT) and radiosurgery. Dr. Himes is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Laminectomy, and Awake Craniotomy.

Mandana Behbahani, MD, is an attending physician and Assistant Professor, Neurological Surgery at Montefiore Einstein. Dr. Behbahani specializes in pediatric neurological surgery with a focus on pediatric neuro-oncology, skull base, neuro-endoscopy, epilepsy, and vascular pathologies. Dr. Behbahani is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Brachial Plexopathy, Rathke Cleft Cyst, Central Pain Syndrome, Tissue Biopsy, and Laminectomy.

Vijay Agarwal, MD, is Associate Professor, Neurosurgery and Associate Professor, Otorhinolaryngology - Head & Neck Surgery at Montefiore Einstein. His clinical focus is on comprehensive treatments for adult patients with benign and malignant brain tumors. Dr. Agarwal specializes in the treatment of patients with primary brain tumors such as gliomas, meningiomas and pituitary tumors, as well as skull base and metastatic brain tumors. In addition, he treats cerebrovascular disease, including intracranial aneurysms and arteriovenous malformations. Dr. Agarwal is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Meningioma, Apoplexy, Pituitary Tumor, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Agarwal is board certified in American Board Of Neurological Surgery.

Stergios Zacharoulis is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Zacharoulis is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Pineocytoma, Glioma, and Brain Stem Cancer. Dr. Zacharoulis is currently accepting new patients.

Mark Souweidane is a Neurosurgery provider practicing medicine in Brooklyn, New York. Dr. Souweidane is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Brain Tumor, Gliomatosis Cerebri, Craniopharyngioma, and Osteotomy. Dr. Souweidane is board certified in American Board Of Pediatric Neurological Surgery and American Board Of Neurological Surgery. Dr. Souweidane is currently accepting new patients.

Tony J. C. Wang, M.D., is the Co-Director of the Center for Radiosurgery, Chair of the Quality and Patient Safety Committee in Radiation Oncology at New York Presbyterian/Columbia University Irving Medical Center, and Professor of Radiation Oncology (in Neurological Surgery) at Columbia University Irving Medical Center. He is recognized internationally for his extensive expertise in malignant and benign brain tumors. His research interests are in Gamma Knife stereotactic radiosurgery and brain tumors resulting in over 100 peer-reviewed publications. He has given over 50 invited lectures and visiting professorships nationally and internationally.He serves on several national and international working groups developing guidelines for brain tumor management and stereotactic radiosurgery. He is an editor for 2 radiation oncology textbooks and a writer for over 15 book chapters. He serves as an Editor of Translational Cancer Research, Assistant Editor on the Radiosurgery & Radiation Oncology Section of Neurosurgery, the official journal of the Congress of Neurological Surgeons, and as a reviewer for JAMA Oncology, Journal of Clinical Oncology, and International Journal of Radiation Oncology, Biology, and Physics as well as many others.Dr. Wang received his B.A. and M.D. degrees from University of Missouri Kansas City Medical School, during which time he was also a Clinical Research Training Program Fellow at the National Institutes of Health, Bethesda, Maryland. He received internship training at Flushing Hospital Medical Center. Dr. Wang received his radiation oncology training at New York Presbyterian Hospital (Columbia campus), where he was Chief Resident from 2011-2012.As a member of the Brain Tumor Center and Pituitary Tumor Center at Columbia, Dr. Wang is part of a multidisciplinary team that brings expertise from multiple specialties, including neurosurgery, neuro-oncology, neuroradiology, and neuro-endocrinology. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Acoustic Neuroma, Metastatic Brain Tumor, Primitive Neuroectodermal Tumor (PNET), and Posterior Fossa Tumor. Dr. Wang is board certified in Radiation Oncology. Dr. Wang is currently accepting new patients.

Dr. Matthew Gallitto is an Assistant Professor of Radiation Oncology and Director of Proton Therapy Services at Columbia University Irving Medical Center. He received his undergraduate degree in Biology with highest honors from New York University, medical degree from the Icahn School of Medicine at Mount Sinai, and PhD from Columbia University Graduate School of Arts and Sciences. He completed his residency training at Columbia University Irving Medical Center, where he served as Chief Resident. Dr. Gallitto is active in NRG Oncology, American Society for Radiation Oncology (ASTRO), and Children's Oncology Group (COG). His clinical interests focus on pediatric and brain cancers. He leads a laboratory focusing on the identification of therapies that synergize with radiation therapy as well as novel methods to overcome the blood-brain barrier to treat pediatric brain cancer. He is an ASCO Young Investigator Award and NIH/NCI Paul Calabresi Career Development Award recipient. Dr. Gallitto is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His clinical expertise encompasses Glioma, Gliomatosis Cerebri, Brain Tumor, Thrombectomy, and Gamma Knife Radiosurgery. Dr. Gallitto is currently accepting new patients.

Mary Welch, MD is an Associate Professor of Neurology at CUMC, in the Division of Neuro-Oncology. Dr. Welch graduated from Chicagos' Northwestern Feinberg School of Medicine. She completed neurology residency here at Columbia, followed by sub-specialty training in neuro-oncology at Memorial Sloan-Kettering Cancer Center. In her second year of fellowship, she earned a Comparative Effectiveness Research Award to attend Columbia's Summer Research Institute at Mailman School of Public Health.Upon completing her training, Dr. Welch worked for several years as a practicing neuro-oncologist and Assistant Professor of Neurology at Montefiore Medical Center in the Bronx. There, she served as principal investigator for numerous phase I and II clinical trials for the treatment of primary and metastatic brain cancer. She also developed a strong research interest in improving patient access to both standard and investigational therapies. In addition to seeing both inpatient and outpatient neuro-oncology patients, Dr. Welch maintains an active research program within the Division of Neuro-Oncology. Dr. Welch is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Welch is board certified in Neurology. Dr. Welch is currently accepting new patients.

Jeffrey Bruce is a Neurosurgery provider practicing medicine in New York, New York. Dr. Bruce is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Bruce is currently accepting new patients.

Jovana Pavisic is a Pediatrics provider practicing medicine in New York, New York. Dr. Pavisic is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Hepatoblastoma, and Acute Lymphoblastic Leukemia (ALL). Dr. Pavisic is board certified in Pediatrics and Pediatric Hematology-Oncology.

James H. Garvin, MD, PhD, is a board-certified pediatric hematologist-oncologist who specializes in the care of children and adolescents with brain tumors. He is Principal Investigator at CUMC for the Head Start Program of radiation-sparing intensive chemotherapy for infants and young children with brain tumors. He was principal investigator for a Children's Oncolgy Group protocol for childhood ependymoma. He also offers novel therapies for recurrent brain tumors through our program's membership in Developmental Therapeutics Program of the COG. In addition, Dr. Garvin started the pediatric bone marrow transplant program, and continues as a member of the BMT group. He has particular interest in autologous transplant for brain tumors and allogeneic transplant for metabolic disorders and bone marrow failure syndromes, as well as supportive care for BMT patients. Dr. Garvin became interested in pediatric hematology/oncology through research during medical school in the laboratory of a pediatric hematologist. He is a member of numerous professional societies in the field. Dr. Garvin is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His clinical expertise encompasses Brain Stem Cancer, Medulloblastoma, Glioma, Chronic Graft Versus Host Disease (cGvHD), and Bone Marrow Transplant. Dr. Garvin is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Garvin is currently accepting new patients.

John Boockvar, MD, is the vice chair of the Department of Neurosurgery at Lenox Hill Hospital and director of the department's Brain Tumor Center, the Pituitary/Neuroendocrine Center, and the New York Head and Neck Institute at Lenox Hill and Manhattan Eye, Ear & Throat hospitals. Dr. Boockvar is a professor of neurological surgery and otolaryngology/head and neck surgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is also an investigator at the Feinstein Institutes for Medical Research, where he directs the Laboratory for Brain Tumor Biology and Therapy. Dr. Boockvar was appointed as an adjunct professor at Cold Spring Harbor Laboratory thanks to his great advancements in understanding and treating brain cancer. He is also head of experimental therapeutics for Northwell Health, where he helps oversee the oncological research goals for Northwell as a whole. Dr. Boockvar's compassionate cancer care was recently highlighted in the critically acclaimed Netflix docuseries Lenox Hill and Emergency NYC.Dr. Boockvar is internationally known for his surgical expertise and for providing patients with safe, effective and minimally invasive treatment for brain tumors, skull base disorders and disorders of the spine. His surgical expertise is in benign and malignant brain tumors, skull base and endoscopic pituitary surgery, spinal and peripheral nerve tumors, minimally invasive spinal surgery, and complex spinal disorders.Dr. Boockvar has been recognized for his novel research in brain tumors and stem cell biology, and has been named to lists including New York Magazine's Top Docs, Best Doctors in New York-Castle Connolly, New York Super Doctors, America's Top Surgeons, America's Best Doctors, and America's Best Doctors for Cancer. His research has been widely published and he has received numerous national awards, including the Eric Lichtenstein Humanitarian Award from Voices Against Brain Cancer for his compassionate work in treating patients with brain cancer. Dr. Boockvar was elected to the prestigious Academy of Neurological Surgeons and was elected to the Senior Society of the American Board of Neurological Surgery. Dr. Boockvar is also an honorary surgeon of the NYPD and the New York State Troopers.Dr. Boockvar received a BA from the University of Pennsylvania. Like his father, grandfather, and great-grandfather before him, Dr. Boockvar received an MD from SUNY Brooklyn-Downstate Medical Center. Dr. Boockvar graduated summa cum laude with Distinction in Research and was medical school class valedictorian. Dr. Boockvar did his surgical internship and neurosurgical residency at the Hospital of the University of Pennsylvania. Dr. Boockvar did his NIH-supported post-doctoral research training in Neuro-oncology at the University of Pennsylvania Cancer Center. Dr. Boockvar is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Brain Tumor, Awake Craniotomy, and Laminectomy. Dr. Boockvar is board certified in American Board Of Neurological Surgery.

Kim Kramer is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Kramer is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma. Dr. Kramer is currently accepting new patients.

Rashmi Verma is a Neurologist practicing medicine in Bronx, New York. Dr. Verma is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Papilledema, Meningitis, Increased Intracranial Pressure, and Pseudotumor Cerebri Syndrome.